Neutralizing antibody test NADAL® COVID-19 S1-NAb Test från tyska Nal von minden, testa om du har fått antikroppar efter vaccination mot Covid-19

Beskrivning

Neutralizing antibody test NADAL® COVID-19 S1-NAb Test från tyska Nal von minden

Kontrollera om din Covid-19 vaccinering var framgångsrik! testa om du har fått antikroppar efter vaccination.

Test för kvalitativ detektion av potentiellt neutraliserande antikroppar mot SARS-CoV-2 i humant helblod, serum eller plasma prover.

Nadal NAB test har hög sensitivitet (>99,9%) och specificitet (99,5%).

Antikroppar kan detekteras, detekterar antikroppar från vaccin som triggar immunresponsen mot S1 enheten av spike-proteinet, såsom de från BioNTech/Pfizer, Moderna®, AstraZeneca, Johnson&Johnson and Sinovac Life Sciences.

Testproceduren är mycket enkel och kräver ingen speciell träning eller kvalifikationer för att utföras. NADAL® COVID-19 S1-NAb Testet är avsett för professionellt bruk.

For the qualitative detection of potentially neutralising antibodies against SARS-CoV-2 in
human whole blood, serum or plasma samples.

Neutralising antibodies against SARS-CoV-2

The effectiveness of vaccines against coronavirus SARS-CoV-2
lies between 65 % and 95 %*. The detection of neutralising
antibodies can determine whether a vaccine has been successful. Following a vaccination or an infection with coronavirus, various antibodies are produced by the immune system.
However, only some of the antibodies formed have a neutralising effect, i.e. they prevent the virus from entering the host
cell. Neutralising antibodies block the spike protein on the
surface of the virus, preventing it from binding to the host
cell’s ACE2 receptors and thus protecting against a severe
course of infection with COVID-19.
These potentially neutralising antibodies against the S1 subunit of the SARS-CoV-2 spike protein can be detected using a
rapid test.

NADAL® COVID-19 S1-NAb Test

The test serves as an aid in determining whether an immune
response to the S1 subunit of the SARS-CoV-2 spike protein
has occurred. Antibodies can be detected against vaccines
that trigger an immune response against the S1 subunit
of the spike protein, such as those from BioNTech/Pfizer,

Moderna®, AstraZeneca, Johnson&Johnson and Sinovac Life
Sciences. The test procedure is not automated and requires
no special training or qualifications. The NADAL® COVID-19
S1-NAb Test is intended for professional use.

Your benefits at a glance:

• Fingerstick blood sample
• Can be carried out using whole blood (venous or
  fingerstick), serum or plasma
• Results in just 2 steps
• Results within 10 minutes
• Detection of potentially neutralising
  antibodies against SARS-CoV-2
  following vaccination or infection
• Detection of potentially neutralising
  antibodies against SARS-CoV-2
  following vaccination or infection
• Storage at room
  temperature possible